The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
APTOSE BIOSCIENCES INC COM NEW 03835T200 2,569 453,040 SH   SOLE 0 453,040 0 0
BELLUS HEALTH INC NEW COM NEW 07987C204 1,672 220,000 SH   SOLE 0 220,000 0 0
CATABASIS PHARMACEUTICALS IN COM NEW 14875P206 3,647 617,084 SH   SOLE 0 617,084 0 0
CUE BIOPHARMA INC COM 22978P106 4,524 285,000 SH   SOLE 0 285,000 0 0
DISNEY WALT CO COM DISNEY 254687106 2,169 15,000 SH   SOLE 0 15,000 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 3,038 203,898 SH   SOLE 0 203,898 0 0
EQUINOX GOLD CORP COM 29446Y502 2,307 300,000 SH   SOLE 0 300,000 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 3,180 40,000 SH   SOLE 0 40,000 0 0
GOLD FIELDS LTD NEW SPONSORED ADR 38059T106 1,650 250,000 SH   SOLE 0 250,000 0 0
INTELSAT S A COM L5140P101 11,468 1,631,227 SH   SOLE 0 1,631,227 0 0
MAXAR TECHNOLOGIES INC COM 57778K105 42,039 2,682,790 SH   SOLE 0 2,682,790 0 0
REATA PHARMACEUTICALS INC CL A 75615P103 39,251 192,000 SH   SOLE 0 192,000 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106 2,024 88,927 SH   SOLE 0 88,927 0 0
TURNING POINT THERAPEUTICS I COM 90041T108 17,753 285,000 SH   SOLE 0 285,000 0 0
UNIQURE NV SHS N90064101 18,094 252,500 SH   SOLE 0 252,500 0 0
VIRGIN GALACTIC HOLDINGS CL A ORD Com 92766K106 27,855 2,411,729 SH   SOLE 0 2,411,729 0 0
VIRGIN GALCTC HLDNG CL A EQY WARRANT W Exp 11/25/2020 92766K114 2,922 252,983 SH Call SOLE 0 252,983 0 0